Facebook Users

Will REPR go up?

REPR Repro-Med Systems Inc. featured news, full reports, and detailed charts

Repro-Med Systems Inc. (REPR/REPR.OB) Wrap Up:

Repro-Med Systems, Inc. engages in the design, manufacture, and marketing of proprietary medical devices primarily for emergency medical applications and ambulatory infusion therapy. It offers the FREEDOM60, a syringe infusion system used in the home health care industry and patient emergency transportation to administer the primary immune deficiency by injecting immune globulin. The company’s FREEDOM60 is also used for treating thalissemia with the drug desferal; for pain control, primarily post-operative epidural pain administration; and for chemotherapy in Europe. Repro-Med also manufactures the FREEDOM60-FM, a flow monitor version that contains a microprocessor controlled occlusion alarm...
www.repro-med.com
33 Employees
Founded in 1980

Repro-Med Systems Inc. (REPR:OTC Bulletin Board Market)

LAST $0.25 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of November 19, 2009 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Repro-Med Systems Inc. (REPR)

OPEN
--
PREVIOUS CLOSE
$0.25
DAY HIGH
--
DAY LOW
--
52 WEEK HIGH
10/14/09 - $0.30
52 WEEK LOW
04/3/09 - $0.08
MARKET CAP
8.9M
AVERAGE VOLUME 3 mo
14.5K
DILUTED EPS TTM
$0.02
SHARES OUTSTANDING
35.6M
REPR Does Not Pay Dividends
P/E TTM
10.2x
K = Thousands  M = Millions  B = Billions

REPR Top Compensated Officers

Mr. Andrew I. Sealfon
Co-Founder, Chairman, Chief Executive Officer...
Age: 63
Total Annual Compensation: $122.5K

Executives, Board Directors

Compensation as of Fiscal Year 2009.

Key developments for Repro-Med Systems Inc. (REPR)

Repro-Med Systems Inc. Announces Resignation of Meyler & Company LLC as Company's Independent Registered Public Accounting Firm

On December 5, 2008, Meyler & Company LLC notified Repro-Med Systems Inc. that it was resigning as the company's Independent Registered Public Accounting Firm. The former Auditor's decision to resign was the result of a disagreement with the audit fees charged for the year ended February 29, 2008.

Repro-Med Systems Inc. Announces Resignation of Nathan Blumberg as Member of Board of Directors

On October 29th, 2008 Dr. Nathan Blumberg resigned from his position as a member of Repro-Med Systems Inc.'s board of directors due to personal health reasons, specifically complications from a treatment for toxoplasmosis. Dr. Blumberg will continue to work with Repro-Med Systems Inc. as a consultant.

Repro-Med Systems Inc. Reports Earnings Results for the Second Quarter Ended Aug. 31, 2008

Repro-Med Systems Inc. reported earnings results for the second quarter ended Aug. 31, 2008. The company reported net income of $279,529 for the second quarter of fiscal 2009. In contrast, the company posted net income of $54,367 for the same quarter in the previous year.

otc, otcbb, pinksheet, REPR, ob Repro-Med Systems Inc.

REPR Competitors

Company Last Change
Ambu International kr103.50 DKK -0.50
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation REPR Industry Range
Price/Earnings 11.6x
Price/Sales 2.5x
Price/Book 8.5x
Price/Cash Flow 9.5x
TEV/Sales 2.2x

REPR

 | 

More Recent News About Repro-Med Systems Inc.

More news for REPR

REPRO MED SYSTEMS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits

Show all filings for REPRO MED SYSTEMS INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for REPRO MED SYSTEMS INC 9-Nov-2009Other Events, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informationa...
Click here to read the whole Article (external link)

New Help for Doctors in Combating H1N1 (Swine Flu)

CHESTER, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- As the outbreak of H1N1 (Swine Flu) intensifies, there is a growing need for greater speed and accuracy in collecting specimens from patients for testing to determine with what they've been infected. The government's Centers for Disease Control and Prevention (CDC) has issued interim guidance covering the collection, processing and testing of patient samples. Many state and local medical authorities have incorporated the CDC's recommendations into their own guidance. That's why Repro-Med Systems, Inc., (OTC Bulletin Board: REPR - News), dba RMS Medical Products of Chester, NY, now offers a Specimen Collection Kit (SCK) for its RES-Q-VAC® portable hand held suction pump. The new kit makes it especially convenient for medical personnel to collect samples in accordance with guidance recommendations and their own local procedures. Samples can come from the nasal passages or throat of a patient suspected to have H1N1, RSV (Respiratory Syncytial Virus) or any other similar illness."Obtaining a reliable sample by inserting a swab deep into nasal passages can be tricky, especially when the patients are children who quickly become uncomfortable," noted Andrew Sealfon, President of RMS Medical Products, Inc. "This outbreak of swine flu seems to be hitting younger age groups especially hard," he added. Sealfon explained, "Using our new Specimen Collection Kit does away with the deep penetration and potential damage of using swab which can also contaminate the specimen. A few drop...
Click here to read the whole Article (external link)

REPRO MED SYSTEMS INC Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

REPRO MED SYSTEMS INC Files SEC form 10-Q, Quarterly Report

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Quarterly Report on Form 10-Q contains certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and information relating to us that are based on the beliefs of the management, as well as assumptions made by and information currently available. Our actual results may vary materially from the forward-looking statements made in this report due to important factors such as uncertainties associated with future operating results, unpredictability related to Food and Drug Administration regulations, introduction of competitive products, limited liquidity, reimbursement related risks, government regulation of the home health care industry, success of the research and development effort, market acceptance of Freedom60(R), availability of sufficient capital to continue operations and dependence on key personnel. When used in this report, the words "estimate," "project," "believe," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect current views with respect to future events based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. These statements involve risks and uncertainties with respect to the ability to raise capital to develop and market new products, acceptance in the market place of new and existing products, ability to penetrate new markets, our success in enforcing and obtaining patents, obtaining required Government approvals and attracting and maintaining key personnel that could cause the actual results to differ...
Click here to read the whole Article (external link)

REPRO MED SYSTEMS INC Files SEC form 10-Q, Quarterly Report

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Quarterly Report on Form 10-Q contains certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and information relating to us that are based on the beliefs of the management, as well as assumptions made by and information currently available. Our actual results may vary materially from the forward-looking statements made in this report due to important factors such as, recent operating losses, uncertainties associated with future operating results, unpredictability related to Food and Drug Administration regulations, introduction of competitive products, limited liquidity, reimbursement related risks, government regulation of the home health care industry, success of the research and development effort, market acceptance of Freedom60(R), availability of sufficient capital to continue operations and dependence on key personnel. When used in this report, the words "estimate," "project," "believe," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect current views with respect to future events based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. These statements involve risks and uncertainties with respect to the ability to raise capital to develop and market new products, acceptance in the market place of new and existing products, ability to penetrate new markets, our success in enforcing and obtaining patents, obtaining required Government approvals and attracting and maintaining key personnel that could cause th...
Click here to read the whole Article (external link)

REPRO MED SYSTEMS INC Files SEC form 10-K, Annual Report

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Annual Report on Form 10-K contains certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and information relating to us that are based on the beliefs of the management, as well as assumptions made by and information currently available. Our actual results may vary materially from the forward-looking statements made in this report due to important factors such as, recent operating losses, uncertainties associated with future operating results, unpredictability related to Food and Drug Administration regulations, introduction of competitive products, limited liquidity, reimbursement related risks, government regulation of the home health care industry, success of the research and development effort, expanding the market of FREEDOM60(R), availability of sufficient capital to continue operations and dependence on key personnel. When used in this report, the words "estimate," "project," "believe," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect current views with respect to future events based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. These statements involve risks and uncertainties with respect to the ability to raise capital to develop and market new products, acceptance in the market place of new and existing products, ability to penetrate new markets, our success in enforcing and obtaining patents, obtaining required Government approvals and attracting and maintaining key personnel that could cause t...
Click here to read the whole Article (external link)

REPRO MED SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers

Show all filings for REPRO MED SYSTEMS INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for REPRO MED SYSTEMS INC 5-Nov-2008Change in Directors or Principal Officers Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes ...
Click here to read the whole Article (external link)

Would you like to leave a comment about Repro-Med Systems Inc. REPR/REPR.OB

Besides Repro-Med Systems Inc. there is more great information available at Realpennies.com